Adams, HP Jr. Cerebral vasculitis. Handb Clin Neurol. 2014;119:475–94.CrossRefGoogle ScholarPubMed

Behrouz, R. The risk of ischemic stroke in major rheumatic disorders. J Neuroimmunol. 2014;277:1–5.Google Scholar

Jastrzebska, M, Czok, ME, Guzik, P. Autoimmune diseases, their pharmacological treatment and the cardiovascular system. Cardiol J. 2013;20:569–76.Google Scholar

Sanna, G, Bertolaccini, ML, Cuadrado, MJ, Khamashta, MA, Hughes, GRV. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology. 2003;42:200–13.Google Scholar

Dafer, RM, Biller, J. Antiphospholipid syndrome: Role of antiphospholipid antibodies in neurology. Hematol Oncol Clin N Am. 2008;22:95–105.CrossRefGoogle ScholarPubMed

Miyakis, S, Locksin, MD, Atsumi, T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.CrossRefGoogle Scholar

Kim, JH, Choi, CG, Choi, SJ, Lee, HK, Suh, DC. Primary antiphospholipid antibody syndrome: Neuroradiologic findings in 11 patients. Korean J Radiol. 2000;1:5–10.Google Scholar

Muscal, E, Brey, RL. Antiphospholipid syndrome and the brain in pediatric and adult patients. Lupus. 2010;19:406–11.Google Scholar

Levine, SR, Deegan, MJ, Futrell, N, Welch, KMA. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology. 1990;40:1181–9.Google Scholar

Rodrigues, CEM, Carvalho, JF, Shoenfeld, Y. Neurological manifestations of antiphospholipid syndrome. Eur J Clin Invest. 2010;40:350–9.CrossRefGoogle ScholarPubMed

Gomez-Puerta, JA, Cervera, R. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun. 2014;48–49:20–5.Google Scholar

Brey, RL. Antiphospholipid antibodies in young adults with stroke. J Thromb Thrombolysis. 2005;20:105–12.Google Scholar

Tuhrim, S. Antiphospholipid antibodies and stroke. Curr Cardiol Rep. 2004;6:130–4.CrossRefGoogle ScholarPubMed

Brey, RL, Chapman, J, Levine, SR, et al. Stroke and the antiphospholipid syndrome: Consensus meeting Taormina 2002. Lupus. 2003;23:508–13.Google Scholar

Muscal, E, Brey, RL. Neurological manifestations of the antiphospholipid syndrome: Risk assessments and evidence-based medicine. Int J Clin Pract. 2007;61:1561–8.CrossRefGoogle ScholarPubMed

Ruiz-Irastorza, G, Hunt, BJ, Khamashta, MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum. 2007;15:1487–95.Google Scholar

Mineo, C. Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep. 2013;15(5):324.CrossRefGoogle ScholarPubMed

Ortel, TL. The antiphospholipid syndrome: What are we really measuring? How do we measure it? And how do we treat it? J Thromb Thrombolysis. 2006;21:79–83.Google Scholar

Jara, LJ, Medina, G, Vera-Lastra, O. Systemic antiphospholipid syndrome and atherosclerosis. Clinic Rev Allerg Immunol. 2007;32:172–7.CrossRefGoogle ScholarPubMed

Kluger, BM, Hughes, RL, Anderson, CA, Hassell, KL. Non-traumatic carotid dissection and stroke associated with anti-phospholipid antibody syndrome: Report of a case and review of the literature. Neurol India. 2008;56:77–8.Google Scholar

Merrill, JT. Antiphospholipid syndrome: What’s new in understanding antiphospholipid antibody-related stroke? Curr Rheumatol Rep. 2006;8:159–61.Google Scholar

Lee, JL, Naguwa, SM, Cheema, GS, Gershwin, ME. Revisiting Libman–Sacks endocarditis: A historical review and update. Clin Rev Allergy Immunol. 2009;36:126–30.Google Scholar

Specker, C, Pernoik, A, Brauckmann, U, Siebler, M, Schneider, M. Detection of cerebral microemboli in APS: Introducing a novel investigation method and implications of analogies with carotid artery disease. Lupus. 1998;7 Suppl 2:S75–80.CrossRefGoogle ScholarPubMed

Moll, S, McCloud, M, Ortel, TL. Subdural hematoma and lupus anticoagulants. Stroke. 1997;28:646–8.Google Scholar

Carangelo, B, Peri, G, Signori, G, Palma, L. Chronic hemispheric subdural hematoma in a patient with antiphospholipid antibody syndrome: Case report. J Neurosurg Sci. 2009;53:141–3.Google Scholar

Ruiz-Irastorza, G, Khamashta, MA, Hunt, BJ, Escudero, A, Cuadrado, MJ, Hughes, GR. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: Analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch Intern Med. 2002;162:1164–9.Google Scholar

Carecchio, M, Cantello, R, Comi, C. Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: Beyond vascular damage. J Immunol Res. 2014;2014:239398.CrossRefGoogle ScholarPubMed

Cervera, R, Boffa, MC, Khamashta, MA, Hughes, GR. The Euro-Phospholipid Project: Epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009;18:889–93.Google Scholar

Carhuapoma, JR, Mitsias, P, Levine, SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke. 1997;28:2363–9.CrossRefGoogle ScholarPubMed

Gezer, S. Antiphospholipid syndrome. Dis Mon. 2003;49:691–741.Google Scholar

Asherson, RA, Cervera, R, de Groot, PG, et al. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530–534.Google Scholar

Bucciarelli, S, Cervera, R, Espinosa, G, et al. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors. Autoimmun Rev. 2006;6:72–5.Google Scholar

Erkan, D, Harrison, MJ, Levy, R, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56:2382–91.Google Scholar

Ruiz-Irastorza, G, Cuadrado, MJ, Ruiz-Arruza, I, et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies. Lupus. 2011;20:206–18.Google Scholar

Levine, SR, Brey, RL, Tilley, BC et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA. 2004;291:576–84.Google ScholarPubMed

Panichpisal, K, Rozner, E, Levine, SR. The management of stroke in antiphospholipid syndrome. Curr Rheumatol Rep. 2012;14:99–105.Google Scholar

Erkan, D, Vega, J, Ramon, G, Kozora, E, Lockshin, MD. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum. 2013;65:464–71.CrossRefGoogle ScholarPubMed

Cuadrado, MJ. Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome). Curr Rheumatol Rep. 2002;4:392–8.Google Scholar

Cohen, H, Machin, SJ. Antithrombotic treatment failures in antiphospholipid syndrome: The new anticoagulants? Lupus. 2010;19:486–91.Google Scholar

Peixoto, MV, de Carvalho, JF, Rodrigues, CE. Clinical, laboratory, and therapeutic analysis of 21 patients with neonatal thrombosis and antiphospholipid antibodies: A literature review. J Immunol Res. 2014;2014:672603.CrossRefGoogle Scholar

Lundstrom, E, Gustafsson, JT, Jonsen, A, et al. HLA-DRB*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis. 2013;72:1018–25.Google Scholar

Hochberg, MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum. 1997;40:1725.Google Scholar

ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.Google Scholar

Van Dam, AP. Diagnosis and pathogenesis of CNS lupus. Rheumatol Int. 1991;11:1–11.Google Scholar

Sibbitt, WL Jr, Sibbitt, RR, Brooks, WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999;42:2026–38.3.0.CO;2-J>CrossRefGoogle ScholarPubMed

Timlin, H, Petri, M. Transient ischemic attack and stroke in systemic lupus erythematosus. Lupus. 2013;22:1251–8.CrossRefGoogle ScholarPubMed

Wierzbicki, AS. Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus. Lupus. 2000;9:194–201.Google Scholar

Jennekens, FG, Kater, L. The central nervous system in systemic lupus erythematous. Part 2. Pathogenetic mechanisms of clinical syndromes: A literature investigation. Rheumatology (Oxford). 2002;41:619–30.Google Scholar

Mitsias, P, Levine, SR. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology. 1994;44:385–93.Google Scholar

Wang, R, Xu, Y, Lv, R, Chen, J. Systemic lupus erythematosus associated with moyamoya syndrome: A case report and literature review. Lupus. 2013;22:629–33.CrossRefGoogle ScholarPubMed

Owada, T, Takahashi, K, Kita, Y. Subarachnoid hemorrhage in systemic lupus erythematosus in Japan: Two case reports and a review of the literature. Mod Rheumatol. 2009;19:573–80.Google Scholar

Nakai, Y, Hyodo, A, Yanaka, K, Akutsu, H, Nose, T. Distal superior cerebellar artery aneurysm in a patient with systemic lupus erythematosus: Case report. Surg Neurol. 2000;54:73–6.Google Scholar

Laversuch, CJ, Brown, MM, Clifton, A, Bourke, BE. Cerebral venous thrombosis and acquired protein S deficiency: An uncommon cause of headache in systemic lupus erythematosus. Br J Rheumatol. 1995;34:572–5.CrossRefGoogle ScholarPubMed

Uthman, I, Khalil, I, Sawaya, R, Taher, A. Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis. Clin Rheumatol. 2004;23:362–3.Google Scholar

Alboudi, A, Sarathchandran, P, Alrukn, S, Al Madani, A. Cerebral venous thrombosis presenting with subdural haematoma as first presentation for systemic lupus erythematosus with negative antiphospholipid antibodies. BMJ Case Rep. 2014: doi: 10.1136/bcr-2014-205355.CrossRefGoogle Scholar

Broussalis, E, Trinka, E, Kraus, J, McCoy, M, Killer, M. Treatment strategies for vasculitis that affects the nervous system. Drug Discov Today. 2013;18:818–35.Google Scholar

Yu, HH, Lee, JH, Wang, LC, Yang, YH, Chiang, BL. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: A 20-year study. Lupus. 2006;15:651–7.Google Scholar

Levy, DM, Massicotte, MP, Harvey, E, Hebert, D, Silverman, ED. Thromboembolism in paediatric lupus patients. Lupus. 2003;12:741–6.Google Scholar

Saini, AG, Sankhyan, N, Bhattad, S, et al. CNS vasculitis and stroke in neonatal lupus erythematosus: A case report and review of literature. Eur J Paediatr Neurol. 2014;18:444–8.CrossRefGoogle ScholarPubMed

Shiboski, CH, Shiboski, SC, Seror, R, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69:35–45.Google Scholar

Niemela, RA, Hakala, M. Primary Sjögren’s syndrome with severe central nervous system disease. Semin Arthritis Rheum. 1999;29:4–13.CrossRefGoogle ScholarPubMed

Segal, B, Carpenter, A, Walk, D. Involvement of nervous system pathways in primary Sjögren’s syndrome. Rheum Dis Clin N Am. 2008;34:885–906.Google Scholar

Simmons-O’Brien, E, Chen, S, Watson, R, et al. One hundred anti-Ro (SS-A) antibody positive patients: A 10-year follow-up. Medicine (Baltimore). 1995;74:109–30.Google Scholar

Ishizaka, S, Hayashi, K, Otsuka, M, et al. Syringomelia and arachnoid cysts associated with spinal arachnoiditis following subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2012;52:686–90.Google Scholar

Marinos, G, Riley, J, Painter, DM, McCaughan, GW. Sulfasalazine-induced fulminant hepatic failure. J Clin Gastroenterol. 1992;14:132–5.Google Scholar

Urban, E, Jabbari, B, Robles, H. Concurrent cerebral venous sinus thrombosis and myeloradiculopathy in Sjögren’s syndrome. Neurology. 1994;44:554–6.Google Scholar

Delalande, S, de Seze, J, Fauchais, AL, et al. Neurologic manifestations in primary Sjögren syndrome: A study of 82 patients. Medicine (Baltimore). 2004;83:280–91.CrossRefGoogle ScholarPubMed

Saip, S, Skman-Demir, G, Siva, A. Neuro-Behçet syndrome. Handb Clin Neurol. 2014;121:1703–23.Google Scholar

International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–80.Google Scholar

Siva, A, Saip, S. The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis. J Neurol. 2009;156:513–29.Google Scholar

Kikuchi, S, Niino, M, Shinpo, K, Terae, S, Tashiro, K. Intracranial hemorrhage in neuro-Behçet’s syndrome. Intern Med. 2002;41:692–5.Google Scholar

Kocak, A, Cayli, SR, Ates, O, Sarac, K. Middle cerebral artery aneurysm associated with Behçet’s disease. Neurol Med Chir (Tokyo). 2004;44:368–71.Google Scholar

Ho, CL, Deruytter, MJ. Manifestations of neuro-Behçet’s disease. Report of two cases and review of the literature. Clin Neurol Neurosurg. 2005;107:310–14.Google Scholar

Aguiar de Sousa, D, Mestre, T, Ferro, JM. Cerebral venous thrombosis in Behçet’s disease: A systematic review. J Neurol. 2011;258:719–27.Google Scholar

Iannetti, L, Zito, R, Bruschi, S, et al. Recent understanding on diagnosis and management of central nervous system vasculitis in children. Clin Dev Immunol. 2012;2012:698327.Google Scholar

Zaiden, M, Mariotte, E, Galicier, L, et al. Vasculitic emergencies in the intensive care unit: A special focus on cryoglobulinemic vasculitis. Ann Intensive Care. 2012;2:31.Google Scholar

De Vita, S, Soldano, F, Isola, M, et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis. 2011;70:1183–90.Google Scholar

Ghetie, D, Mehraban, N, Sibley, CH. Cold hard facts of cryoglobulinemia: Updates on clinical features and treatment advances. Rheum Dis Clin North Am. 2015;41:93–108.Google Scholar

Mazzola, L, Antoine, JC, Camdessanche, JP, et al. Brain hemorrhage as a complication of type I cryoglobulinemia vasculopathy. J Neurol. 2003;250:1376–8.Google Scholar

Adinolfi, LE, Zampino, R, Restivo, L, et al. Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. World J Gastroenterol. 2014;20:3410–17.Google Scholar

Ramos-Casals, M, Robles, A, Brito-Zeron, P, et al. Life-threatening cryoglobulinemia: Clinical and immunological characterization of 29 cases. Semin Arthritis Rheum. 2006;36:189–96.Google Scholar

Holle, JU, Gross, WL. Neurological involvement in Wegener’s granulomatosis. Curr Opin Rheumatol. 2011;23:7–11.Google Scholar

American College of Rheumatology. 1990 Criteria for the classification of Wegener’s granulomatosis (now known as granulomatosis with polyangiitis). http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/ACR-Endorsed-Criteria. Accessed 28 November 2015.Google Scholar

de Leeuw, K, Sanders, JS, Stegeman, C, et al. Accelerated atherosclerosis in patients with Wegener’s granulomatosis. Ann Rheum Dis. 2005;64:753–9.CrossRefGoogle ScholarPubMed

Davison, R, Sheerin, NS. Granulomatosis with polyangiitis presenting as ischaemic stroke. JRSM Short Rep. 2012;3:81.Google Scholar

Nowack, R, Wachtler, P, Kunz, J, Rasmussen, N. Cranial nerve palsy in Wegener’s granulomatosis: Lessons from clinical cases. J Neurol. 2009;256:299–304.Google Scholar

Nesher, G. The diagnosis and classification of giant cell arteritis. J Autoimmun. 2014;48–49:73–5.Google Scholar

Chatterjee, S, Flamm, SD, Tan, CD, Rodriguez, ER. Clinical diagnosis and management of large vessel vasculitis: Giant cell arteritis. Curr Cardiol Rep. 2014;16:498.Google Scholar

Ness, T, Bley, TA, Schmidt, WA, Lamprecht, P. The diagnosis and treatment of giant cell arteritis. Dtsch Arztebl Int. 2013;110:376–85.Google Scholar

Weyand, CM, Goronzy, JJ. Giant-cell arteritis and polymyalgia rheumatic. N Engl J Med. 2014;371:50–7.Google Scholar

American College of Rheumatology. 1990 Criteria for the classification of giant cell (temporal) arteritis – excerpt. http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/ACR-Endorsed-Criteria. Accessed 28 November 2015.Google Scholar

Mollan, SP, Sharrack, N, Burdon, MA, Denniston, AK. Aspirin as adjunctive treatment for giant cell arteritis. Cochrane Database Syst Rev. 2014;8:CD010453.Google Scholar

Caylor, TL, Perkins, A. Recognition and management of polymyalgia rheumatica and giant cell arteritis. Am Fam Physician. 2013;88:676–84.Google Scholar

Smith, JH, Swanson, JW. Giant cell arteritis. Headache. 2014;54:1273–89.Google Scholar

Mahr, AD, Jover, JA, Spiera, RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis. Arthritis Rheum. 2007;86:2789–97.Google Scholar

Martinez-Taboada, VM, Lopez-Hoyos, M, Narvaez, J, Munoz-Cacho, P. Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: A cumulative meta-analysis. Autoimmun Rev. 2014;13:788–94.Google Scholar

Gupta, V, Chinchure, SD, Goel, G, et al. Coil embolization of intracranial aneurysm in polyarteritis nodosa. A case report and review of the literature. Interv Neuroradiol. 2013;19:203–8.Google Scholar

American College of Rheumatology. 1990 Criteria for the Classification of polyarteritis nodosa. http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/ACR-Endorsed-Criteria. Accessed 28 November 2015.Google Scholar

Pagnoux, C, Seror, R, Henegar, C, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: A systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum. 2010;62:6116–26.Google Scholar

Reichart, MD, Bogousslavsky, J, Janzer, RC. Early lacunar strokes complicating polyarteritis nodosa: Thrombotic microangiopathy. Neurology. 2000;54:883–9.Google Scholar

Provenzale, JM, Allen, NB. Neuroradiologic findings in polyarteritis nodosa. AJNR Am J Neuroradiol. 1996;17:1119–26.Google ScholarPubMed

Ford, RG, Siekert, RG. Central nervous system manifestations of periarteritis nodosa. Neurology. 1965;15:114–22.Google Scholar

Hajj-Ali, RA, Calabrese, LH. Diagnosis and classification of central nervous system vasculitis. J Autoimmun. 2014;48–49:149–52.Google Scholar

Calabrese, LH, Mallek, JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic critera. Medicine (Baltimore). 1988;67:20–39.Google Scholar

Birnbaum, J, Hellmann, DB. Primary angiitis of the central nervous system. Arch Neurol. 2009;66:704–9.Google Scholar

Berlit, P, Kraemer, M. Cerebral vasculitis in adults: What are the steps in order to establish the diagnosis? Red flags and pitfalls. Clin Exp Immunol. 2013;175:419–24.Google Scholar

Lucke, M, Hajj-Ali, RA. Advances in primary angiitis of the central nervous system. Curr Cardiol Rep. 2014;16:533.Google Scholar

Suri, V, Kakkar, A, Sharma, MC, et al. Primary angiitis of the central nervous system: A study of histopathological patterns and review of the literature. Folia Neuropathol. 2014;52:187–96.Google Scholar

Merkel, PA, Koroshetz, WJ, Irizarry, MC, Cudkowicz, ME. Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum. 1995;25:172–83.Google Scholar

Hajj-Ali, RA, Calabrese, LH. Primary angiitis of the central nervous system. Autoimmunity Reviews. 2013;12:463–6.Google Scholar

Nogueras, C, Sala, M, Sasal, M, et al. Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with human immunodeficiency virus. Arch Neurol. 2002;59:468–73.Google Scholar

Yasuda, Y, Matsuda, I, Kang, Y, Saiga, T, Kameyama, M. Isolated angiitis of the central nervous system first presenting as intracranial hemorrhage during cesarean section. Intern Med. 1993;32:745–8.Google Scholar

Biller, J, Loftus, CM, Moore, SA, et al. Isolated central nervous system angiitis first presenting as spontaneous intracranial hemorrhage. Neurosurgery. 1987;20:310–15.Google Scholar

Ozawa, T, Sasaki, O, Sorimachi, T, Tanaka, R. Primary angiitis of the central nervous system: Report of two cases and review of the literature. Neurosurgery. 1995;36:173–9.Google Scholar

Twilt, M, Benseler, SM. The spectrum of CNS vasculitis in children and adults. Nat Rev Rheumatol. 2012;8:97–107.Google Scholar

Gowdie, P, Twilt, M, Benseler, SM. Primary and secondary central nervous system vasculitis. J Child Neurol. 2012;27:1448–59.Google Scholar

Park, MS, Marlin, AE, Gaskill, SJ. Angiography-negative primary angiitis of the central nervous system in childhood. J Neurosurg Pediatr. 2014;13:62–7.Google Scholar

Cellucci, T, Benseler, SM. Central nervous system vasculitis in children. Curr Opin Rheumatol. 2010;22:590–7.Google Scholar

Pistracher, K, Gellner, V, Riegler, S, et al. Cerebral haemorrhage in the presence of primary childhood central nervous system vasculitis: A review. Childs Nerv Syst. 2012;28:1141–8.Google Scholar

Hutchinson, C, Elbers, J, Halliday, W, et al. Treatment of small vessel primary CNS vasculitis in children: An open-label cohort study. Lancet Neurol. 2010;9:1078–84.Google Scholar

Aletaha, D, Neogi, T, Silman, AJ, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–81.Google Scholar

Meune, C, Touze, E, Trinquart, L, Allanore, Y. High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis. 2010;103:253–61.Google Scholar

Kitas, GD, Gabriel, SE. Cardiovascular disease in rheumatoid arthritis: State of the art and future perspectives. Ann Rheum Dis. 2011;70:8–14.Google Scholar

Dhawan, SS, Quyyumi, AA. Rheumatoid arthritis and cardiovascular disease. Curr Atheroscler Rep. 2008;10:128–33.Google Scholar

Ruyssen-Weitrand, A, Fautrel, B, Saraux, A, Loet, XL, Pham, T. Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: A systematic literature review. Joint Bone Spine. 2011;78:23–30.CrossRefGoogle Scholar

Ohno, T, Matsuda, I, Furukawa, H, Kanoh, T. Recovery from rheumatoid cerebral vasculitis by low-dose methotrexate. Internal Medicine. 1994;33:615–20.Google Scholar

De Carvalho, M, Swash, M. Neurologic complications of craniovertebral dislocation. Handb Clin Neurol. 2014;119:435–48.Google Scholar

Mills, JA, Michel, BA, Bloch, DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum. 1990;33:1114–21.Google Scholar

Berube, MD, Blais, N, Lanthier, S. Neurologic manifestations of Henoch–Schönlein purpura. Handb Clin Neurol. 2014;120:1101–11.Google Scholar

van den Hoogen, F, Khanna, D, Fransen, J, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47.Google Scholar

Amaral, TN, Peres, FA, Lapa, AT, Marques-Neto, JF, Appenzeller, S. Neurologic involvement in scleroderma: A systematic review. Semin Arthritis Rheumatism. 2013;43:335–47.Google Scholar

Das, CP, Rabhakar, S, Lal, V, Kharbanda, PS. Scleroderma, stroke, optic neuropathy: A rare association. Neurol India. 2002;50:504–7.Google Scholar

Smith, JA. Update on ankylosing spondylitis: Current concepts in pathogenesis. Curr Allergy Asthma Rep. 2015;15:489.Google Scholar

van Tubergen, A, Weber, U. Diagnosis and classification in spondyloarthritis: Identifying a chameleon. Nat Rev Rheumatol. 2012;8:253–61.Google Scholar

van der Linden, S, Valkenburg, HA, Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8.Google Scholar

Mathieu, S, Gossec, L, Dougados, M, Soubrier, M. Cardiovascular profile in ankylosing spondylitis: A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:557–63.Google Scholar

Kaprove, RE, Little, AH, Graham, DC, Rosen, PS. Ankylosing spondylitis: Survival in men with and without radiotherapy. Arthritis Rheum. 1980;23:57–61.Google Scholar

Dutra, LA, Braga-Neto, P, Pedroso, JL, Barsottini, OG. Sneddon’s syndrome: Case report and review of its relationship with antiphospholipid syndrome. Einstein (Sao Paulo). 2012;10:230–2.Google Scholar

Bolayir, E, Yilmaz, A, Kugu, N, Erdogan, H, Akyol, M, Akyuz, A. Sneddon’s syndrome: Clinical and laboratory analysis of 10 cases. Acta Med Okayama. 2004;58:59–95.Google Scholar

Wu, S, Xu, Z, Liang, H. Sneddon’s syndrome: A comprehensive review of the literature. Orphanet J Rare Dis. 2014;9:215.Google Scholar

Rebollo, M, Val, JF, Garijo, F, Quintana, F, Berciano, J. Livedo reticularis and cerebrovascular lesions (Sneddon’s syndrome). Clinical, radiological and pathological features in eight cases. Brain. 1983;106:965–79.Google Scholar

Wu, W, Chaer, RA. Nonarteriosclerotic vascular disease. Surg Clin North Am. 2013;93:833–75.Google Scholar

American College of Rheumatology. 1990 criteria for the classification of Takayasu arteritis. http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/ACR-Endorsed-Criteria. Accessed 28 November 2015.Google Scholar

Chatterjee, S, Flamm, SD, Tan, CD, Rodriguez, ER. Clinical diagnosis and management of large vessel vasculitis: Takayasu arteritis. Curr Cardiol Rep. 2014;16:499.Google Scholar

American College of Rheumatology. 1990 criteria for the classification of Churg-Strauss syndomre (traditional format), their sensitivity and specificity versus other defined vasculitis syndromes. http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/ACR-Endorsed-Criteria. Accessed 28 November 2015.Google Scholar

Burns, JC, Glode, MP. Kawasaki syndrome. Lancet. 2004;364:533–44.Google Scholar

Chowdhury, SR, Majumder, S, Chakraborty, PP, et al. Headache in a case of Rhupus syndrome. Headache. 2008;48:155–8.Google Scholar